Sleep Well At Night Portfolio
A collection of premium defensive stocks expertly selected by our analysts to help protect your investments during market turbulence. These industry giants offer stability through consistent earnings, reliable dividends, and proven resilience in any economic climate.
Top Picks from This Group
Here are a few of the assets in this group. Create an account to unlock the full list.
About This Group of Stocks
Our Expert Thinking
This portfolio focuses on companies providing essential goods and services that people need regardless of economic conditions. From healthcare to utilities to household necessities, these businesses maintain steady demand even when markets get shaky, helping to preserve your capital while still generating returns.
What You Need to Know
These are primarily blue-chip companies with strong balance sheets, low debt, and established histories of rewarding shareholders. They typically show less dramatic price swings than the broader market, making them ideal for investors who prioritize stability and predictable performance over aggressive growth.
Why These Stocks
Each company was selected for its dominant market position, consistent cash flows, and proven ability to weather economic storms. These aren't just random defensive picks - they're category leaders with essential products, loyal customers, and business models specifically designed to maintain stability through market cycles.
12 Month Growth Potential
Use the growth calculator to see how much investing in these assets could return over one year.
If you invested across these assets:
in 12 months it could be worth:
+15.30%
Group Performance Snapshot
Average 12 Month Profit
On average, analysts expect assets in this group to grow 15.3% over the next year.
Stocks Rated Buy by Analysts
13 of 15 assets in this group are rated Buy by professional analysts.
Group Growth
This group averaged a 3% return last month.
Why You'll Want to Watch These Stocks
Market Turbulence Shield
When markets get choppy, these companies typically remain steady. Their essential products and services keep revenue flowing regardless of economic ups and downs.
Dividend Income Machine
These blue-chip companies have long histories of not just paying dividends but increasing them over time. That means potential passive income that grows year after year.
Industry Leaders Only
Every company in this collection dominates its category. With established customer bases and powerful brands, they're built to maintain their market positions for years to come.
Why Invest with Nemo Money?
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
6% Interest on Cash
Earn 6% AER on uninvested cash with daily interest payments.
Discover More Opportunities
The New Cost of Compliance: Investing in HR Tech
Australian airline Qantas received a historic $58 million fine for unlawfully dismissing workers, setting a new precedent for corporate accountability in labor practices. This ruling creates an investment opportunity in companies that provide the essential HR, legal, and compliance technologies businesses now need to navigate stricter labor law enforcement.
GLP-1s Target Liver Disease
The FDA's approval of Wegovy for a serious liver disease has boosted Novo Nordisk's market position and highlighted a major new application for GLP-1 drugs. This development creates an investment opportunity in companies focused on innovative treatments for metabolic and liver-related conditions.
Pharma's Digital Prescription
Novo Nordisk is partnering with GoodRx to offer its popular drug Ozempic at a reduced price, boosting GoodRx's stock. This collaboration highlights a growing trend of pharmaceutical companies leveraging digital health platforms to improve drug affordability and expand market reach.
Frequently Asked Questions
Everything you need to know about the product and billing.